Ovidrel - 44087-1150-1 - (choriogonadotropin alfa)

Alphabetical Index


Drug Information of Ovidrel

Product NDC: 44087-1150
Proprietary Name: Ovidrel
Non Proprietary Name: choriogonadotropin alfa
Active Ingredient(s): 250    ug/.5mL & nbsp;   choriogonadotropin alfa
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Ovidrel

Product NDC: 44087-1150
Labeler Name: EMD Serono, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021149
Marketing Category: NDA
Start Marketing Date: 20031006

Package Information of Ovidrel

Package NDC: 44087-1150-1
Package Description: 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) > .5 mL in 1 SYRINGE, GLASS

NDC Information of Ovidrel

NDC Code 44087-1150-1
Proprietary Name Ovidrel
Package Description 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) > .5 mL in 1 SYRINGE, GLASS
Product NDC 44087-1150
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name choriogonadotropin alfa
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20031006
Marketing Category Name NDA
Labeler Name EMD Serono, Inc.
Substance Name CHORIOGONADOTROPIN ALFA
Strength Number 250
Strength Unit ug/.5mL
Pharmaceutical Classes Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient]

Complete Information of Ovidrel


General Information